AtriCure Past Earnings Performance
Past criteria checks 0/6
AtriCure has been growing earnings at an average annual rate of 7.1%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 14.3% per year.
Key information
7.1%
Earnings growth rate
11.0%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 14.3% |
Return on equity | -6.5% |
Net Margin | -7.6% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?
Mar 14Investors Interested In AtriCure, Inc.'s (NASDAQ:ATRC) Revenues
Jan 21Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?
Nov 29AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price
Sep 27Health Check: How Prudently Does AtriCure (NASDAQ:ATRC) Use Debt?
Aug 02AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Matching Investor Opinion
Jun 15Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Apr 14Calculating The Intrinsic Value Of AtriCure, Inc. (NASDAQ:ATRC)
Mar 02What Does AtriCure, Inc.'s (NASDAQ:ATRC) Share Price Indicate?
Feb 09Is AtriCure (NASDAQ:ATRC) Using Debt In A Risky Way?
Dec 28Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?
Sep 06An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued
Aug 02AtriCure: 5x Sales For A Series Of Impeding Losses? No Thanks
Jun 13Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Jun 08Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?
May 08Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Is AtriCure (NASDAQ:ATRC) A Risky Investment?
Feb 18Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching
Jan 20Robust Earnings May Not Tell The Whole Story For AtriCure (NASDAQ:ATRC)
Nov 11Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?
Oct 21Revenue & Expenses BreakdownBeta
How AtriCure makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 399 | -30 | 258 | 74 |
30 Sep 23 | 381 | -25 | 241 | 67 |
30 Jun 23 | 366 | -28 | 241 | 62 |
31 Mar 23 | 349 | -38 | 235 | 59 |
31 Dec 22 | 330 | -46 | 231 | 57 |
30 Sep 22 | 316 | -56 | 229 | 57 |
30 Jun 22 | 303 | 53 | 221 | 54 |
31 Mar 22 | 290 | 52 | 214 | 51 |
31 Dec 21 | 274 | 50 | 205 | 49 |
30 Sep 21 | 259 | 45 | 190 | 46 |
30 Jun 21 | 243 | -57 | 174 | 45 |
31 Mar 21 | 213 | -49 | 151 | 43 |
31 Dec 20 | 207 | -48 | 151 | 43 |
30 Sep 20 | 210 | -46 | 147 | 45 |
30 Jun 20 | 212 | -50 | 157 | 45 |
31 Mar 20 | 230 | -46 | 165 | 45 |
31 Dec 19 | 231 | -35 | 167 | 41 |
30 Sep 19 | 222 | -23 | 159 | 37 |
30 Jun 19 | 216 | -20 | 150 | 35 |
31 Mar 19 | 209 | -17 | 144 | 34 |
31 Dec 18 | 202 | -21 | 140 | 35 |
30 Sep 18 | 195 | -20 | 135 | 34 |
30 Jun 18 | 187 | -20 | 130 | 33 |
31 Mar 18 | 180 | -27 | 126 | 34 |
31 Dec 17 | 175 | -27 | 121 | 34 |
30 Sep 17 | 170 | -33 | 116 | 36 |
30 Jun 17 | 166 | -32 | 111 | 37 |
31 Mar 17 | 160 | -34 | 109 | 37 |
31 Dec 16 | 155 | -33 | 105 | 36 |
30 Sep 16 | 150 | -36 | 106 | 34 |
30 Jun 16 | 143 | -35 | 102 | 32 |
31 Mar 16 | 135 | -32 | 97 | 29 |
31 Dec 15 | 129 | -27 | 91 | 26 |
30 Sep 15 | 123 | -22 | 85 | 23 |
30 Jun 15 | 118 | -16 | 83 | 22 |
31 Mar 15 | 112 | -14 | 78 | 20 |
31 Dec 14 | 107 | -16 | 78 | 19 |
30 Sep 14 | 99 | -16 | 74 | 17 |
30 Jun 14 | 93 | -18 | 68 | 15 |
31 Mar 14 | 87 | -17 | 65 | 14 |
31 Dec 13 | 81 | -11 | 57 | 13 |
30 Sep 13 | 78 | -9 | 50 | 13 |
30 Jun 13 | 74 | -8 | 47 | 12 |
31 Mar 13 | 72 | -8 | 45 | 12 |
Quality Earnings: ATRC is currently unprofitable.
Growing Profit Margin: ATRC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ATRC is unprofitable, but has reduced losses over the past 5 years at a rate of 7.1% per year.
Accelerating Growth: Unable to compare ATRC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ATRC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.7%).
Return on Equity
High ROE: ATRC has a negative Return on Equity (-6.53%), as it is currently unprofitable.